Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059321
Filing Date
2025-04-28
Accepted
2025-04-28 16:15:04
Documents
8
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnov_proxy_2025.htm DEF 14A 808026
2 GRAPHIC img138344841_0.jpg GRAPHIC 3617
3 GRAPHIC img138344841_1.jpg GRAPHIC 1349
4 GRAPHIC img138344841_2.jpg GRAPHIC 3617
5 GRAPHIC img138344841_3.jpg GRAPHIC 1349
6 GRAPHIC img138344841_4.jpg GRAPHIC 523380
7 GRAPHIC img138344841_5.jpg GRAPHIC 520105
8 GRAPHIC img138344841_6.jpg GRAPHIC 1349
  Complete submission text file 0000950170-25-059321.txt   2261727
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33185 | Film No.: 25880530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)